| 000 | 01409 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513041942.0 | ||
| 264 | 0 | _c19950608 | |
| 008 | 199506s 0 0 eng d | ||
| 022 | _a0014-2972 | ||
| 024 | 7 |
_a10.1111/j.1365-2362.1995.tb01530.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmit, J W | |
| 245 | 0 | 0 |
_aHeterozygous familial hypercholesterolaemia is associated with pathological exercise-induced leakage of muscle proteins, which is not aggravated by simvastatin therapy. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical investigation _cFeb 1995 |
||
| 300 |
_a79-84 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCreatine Kinase _xblood |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xdrug therapy |
| 650 | 0 | 4 |
_aLovastatin _xanalogs & derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aMyoglobin _xblood |
| 650 | 0 | 4 |
_aPhysical Exertion _xdrug effects |
| 650 | 0 | 4 | _aSimvastatin |
| 700 | 1 | _aBär, P R | |
| 700 | 1 | _aGeerdink, R A | |
| 700 | 1 | _aErkelens, D W | |
| 773 | 0 |
_tEuropean journal of clinical investigation _gvol. 25 _gno. 2 _gp. 79-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2362.1995.tb01530.x _zAvailable from publisher's website |
| 999 |
_c7736635 _d7736635 |
||